Literature DB >> 2112396

Susceptibility to AIDS progression appears early in HIV infection.

M T Schechter1, K J Craib, T N Le, J S Montaner, B Douglas, P Sestak, B Willoughby, M V O'Shaughnessy.   

Abstract

To investigate whether predictors of AIDS progression are operative very early in the natural history of HIV infection, we conducted a nested case-control study within a cohort of 119 subjects who seroconverted while under observation in a prospective study of homosexual men. For each of the 18 cases who have progressed to AIDS, we randomly selected three controls who had seroconverted within 3 months of the case but who have remained AIDS-free. Cases and controls were compared with regard to laboratory and clinical parameters obtained at the time of the earliest HIV-positive result. The median duration between the estimated date of seroconversion and this first positive result was 4 months for cases and 6 months for controls. Cases exhibited lower CD4 counts (657 versus 774 x 10(6)/l; P = 0.037), lower CD4: CD8 ratios (0.98 versus 1.39; P = 0.003), higher immune complex levels (C1q binding: 25 versus 15%; P = 0.002), lower hemaglobin concentrations (14.8 versus 15.2 g/l; P = 0.011), higher immunoglobulin (Ig) A levels (272 versus 184 mg/dl; P = 0.003), and higher IgG levels (1530 versus 1300 mg/dl; P = 0.037) than controls. Cases exhibited higher CD8 counts of marginal statistical significance (732 versus 597 x 10(6)/l; P = 0.059). No differences were observed with respect to IgM levels, total lymphocyte or white blood cell counts, or the frequency of generalized lymphadenopathy. A total of 27.8% of cases but only 11.5% of controls reported one or more symptoms during the 6-month period preceding the first positive visit (P = 0.027). We conclude that laboratory and clinical abnormalities which are predictive of more rapid progression to AIDS may appear very early in HIV infection. This suggests that some of the factors responsible for more rapid disease progression are present in the host prior to or shortly after infection occurs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2112396     DOI: 10.1097/00002030-199003000-00002

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  7 in total

1.  Early Clinical Signs and Symptoms of HIV Infection: Delaying progression to AIDS.

Authors:  L J Miedzinski
Journal:  Can Fam Physician       Date:  1992-06       Impact factor: 3.275

2.  Symptomatic HIV seroconverting illness is associated with more rapid neurological impairment.

Authors:  M R Wallace; J A Nelson; J A McCutchan; T Wolfson; I Grant
Journal:  Sex Transm Infect       Date:  2001-06       Impact factor: 3.519

3.  Acute Retroviral Syndrome Is Associated With High Viral Burden, CD4 Depletion, and Immune Activation in Systemic and Tissue Compartments.

Authors:  Trevor A Crowell; Donn J Colby; Suteeraporn Pinyakorn; James L K Fletcher; Eugène Kroon; Alexandra Schuetz; Shelly J Krebs; Bonnie M Slike; Louise Leyre; Nicolas Chomont; Linda L Jagodzinski; Irini Sereti; Netanya S Utay; Robin Dewar; Rungsun Rerknimitr; Nitiya Chomchey; Rapee Trichavaroj; Victor G Valcour; Serena Spudich; Nelson L Michael; Merlin L Robb; Nittaya Phanuphak; Jintanat Ananworanich
Journal:  Clin Infect Dis       Date:  2018-05-02       Impact factor: 9.079

4.  Elevated CD8 counts during HAART are associated with HIV virologic treatment failure.

Authors:  Elizabeth M Krantz; Katherine Huppler Hullsiek; Jason F Okulicz; Amy C Weintrob; Brian K Agan; Nancy F Crum-Cianflone; Anuradha Ganesan; Tomas M Ferguson; Braden R Hale
Journal:  J Acquir Immune Defic Syndr       Date:  2011-08-15       Impact factor: 3.731

Review 5.  Primary infection by type 1 human immunodeficiency virus: diagnosis and prognosis.

Authors:  P Vanhems; R Beaulieu
Journal:  Postgrad Med J       Date:  1997-07       Impact factor: 2.401

Review 6.  Immunopathogenesis of asymptomatic chronic HIV Infection: the calm before the storm.

Authors:  Emily S Ford; Camille E Puronen; Irini Sereti
Journal:  Curr Opin HIV AIDS       Date:  2009-05       Impact factor: 4.283

7.  Treatment of Primary HIV.

Authors:  Joanne Stekler; Ann Collier
Journal:  Curr Infect Dis Rep       Date:  2002-02       Impact factor: 3.663

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.